Thinly covered — the yield is the price collapse, not the payout. A 15.06% yield on $0.0833 a month ($1.00 a year) looks outsized because the price halved: down about 48% year to date to $6.64, against a $12.80 NAV at June 30. The new rate is just covered — Q2 net investment income of $0.26 a share against the $0.25 quarterly equivalent — but only after two cuts in 2026, from $0.1333 to $0.1133 and then to $0.0833 a month, and with 8.5% of the portfolio at cost on non-accrual. Covered, barely; compounding, no.
Key risk: Credit — 8.5% of portfolio cost on non-accrual at June 30; further borrower failures cut NII first and force a third cut in 2026's sequence.
Changes if: NII falls below the $0.25 quarterly equivalent, or non-accruals rise from 8.5% of cost. Coverage this thin has no room for a bad quarter.
- !Coverage check: Q2 NII of $0.26 against the $0.25 quarterly equivalent of the new monthly rate — about 96% paid out, with almost no cushion.
- !Yield check: 15.06% indicated — $0.0833/mo × 12 at the $6.64 close on Oct. 23, 2026. The yield is mostly a halved price, not a raised payout.
- !NAV check: NAV of $12.80 at June 30, 2026, up 2% in Q2, but the $6.64 price is roughly half NAV, and non-accruals were 8.5% of portfolio cost.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.